Searched for
CIPLA BOARD DRUG
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- Cipla appoints health chief Shivam Puri to lead One India businessCipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take...
- Mounjaro sales dip amid price war as semaglutide generics gain groundMounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...
- Naina Lal Kidwai resigns from Cipla boardDrug major Cipla on Wednesday said Naina Lal Kidwai has resigned as independent director on its board, with effect from March 31, 2022. In ...
- SC refers 349 FDC medicines to Drug Advisory Board for relookA bench said that the 349 FDCs were banned pursuant to the Kokate Committee report, by notifications of the central government under Sectio...
- Cipla appoints Peter Lankau as independent directorLankau is currently a principal of Lankau Consulting LLC. He serves on the Board of Directors of ANI Pharmaceuticals Inc and Phosphagenics ...
- Cipla completes share allocation to FIL Capital InvestmentsCipla today said its arm Cipla Health has completed allocation of shares to FIL Capital Investments II Ltd. It inked an investment agreemen...
- Cipla gets CCI nod for investment by FIL CapitalDrug major Cipla said it has received approval from CCI over the proposed investment by Mauritius-based FIL Capital Investments.
- Cipla to transfer consumer healthcare business to subsidiaryCipla Health was incorporated on August 27, 2015 to focus on the consumer healthcare space.
- Cipla appoints Naina Lal Kidwai as an independent directorIndia's third largest drug maker Cipla has appointed Naina Lal Kidwai on its board as an independent director.
- Cipla elevates Samina Vaziralli to its boardCipla today announced the appointment of Samina Vaziralli as executive director on its board, paving way for a bigger role for her.
- Cipla to invest upto 100 million pounds in UK as part of expansionThe company will provide high quality affordable medicines to British National Health Service (NHS).
- Cipla puts Medpro buyout on hold over valuation issuesCipla decides to put on hold its $220-million acquisition plan of the third-largest South African drugmaker Cipla Medpro due to valuation i...
- Cipla Medpro likely to push India's Cipla to raise bidCipla Ltd is to offer 8.55 rand per share for a 51 percent stake in Cipla Medpro. The Indian group supplies drugs to the Cape Town-based co...
- HC order against marketing of Cipla's anti-cancer drug stayedThe Supreme Court today stayed for a month a Delhi High Court order restraining pharma major Cipla from marketing its anti-cancer drug "Sun...
- Cipla looks to acquire 25% stake in South African coCipla said it could take a decision to buy stake of up to 25 per cent in South Africa-based, Cipla Medpro in next board meeting. Cipla Medp...
- Cipla approves special interim dividend; acquisition of MeditabDrug major Cipla today said its board has approved the acquisition of Mumbai-based Meditab Specialities for a consideration of Rs 133.35 cr...
- Adcock's plan to buy Medpro hits Cipla hurdleSouth African company Adcock Ingram's plans to buy Cipla Medpro, with whom Cipla has a 20-year drug-supply agreement, has run into trouble ...
- Anti-AIDS blitz sees pharma firms locked in ugly battleIt has now emerged that Aids Healthcare Foundation (AHF), the US-based NGO that accused Cipla of over pricing anti-AIDS drug, Viraday, in I...
- Exports pump up Cipla net 53%Buoyed by higher exports and local sales, net profit of pharma firm Cipla rose 52.9% to Rs 170.4 crore for June quarter, reports Our Bureau...
Load More
